Dipòsit Digital de Documents de la UAB 22 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
4 p, 334.8 KB Asthma-COPD overlap is not a homogeneous disorder : Further supporting data / Pérez-de-Llano, Luis (Hospital Universitario Lucus Augusti (Lugo)) ; Cosio, Borja G. (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Iglesias, Amanda (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; de las Cuevas, Natividad (Hospital 12 de Octubre (Madrid)) ; Soler-Cataluña, Juan Jose (Hospital Arnau de Vilanova (València)) ; Izquierdo, Jose Luis (Hospital Universitario de Guadalajara) ; López-Campos, Jose Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Calero, Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Torrego, Alfons (Institut d'Investigació Biomèdica Sant Pau) ; Moragón, Eva Martínez (Hospital Universitari Doctor Peset (València)) ; Soriano, Joan B. (Universidad Autónoma de Madrid) ; Viña, Antolin Lopez (Hospital Puerta de Hierro (Madrid)) ; Bobolea, Irina (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Asthma-COPD ovelap (ACO) is an umbrella term that encompasses patients with COPD and eosinophilic inflammation (e-COPD) and smoking asthmatics with non-fully reversible airflow obstruction (SA). We compared the clinical characteristics and the inflammatory profile of e-COPD and SA. [...]
2017 - 10.1186/s12931-017-0667-x
Respiratory Research, Vol. 18 Núm. 1 (february 2017) , p. 183  
2.
10 p, 1.1 MB Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain : The SEPAR National Registry / Fernández-Fabrellas, Estrella (Consorcio Hospital General Universitario València) ; Molina Molina, Maria (Hospital Universitari de Bellvitge) ; Soriano, Joan B. (Hospital Universitario de la Princesa (Madrid)) ; Rodríguez Portal, José Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Ancochea, Julio (Hospital Universitario de la Princesa (Madrid)) ; Valenzuela, Claudia (Hospital Universitario de la Princesa (Madrid)) ; Xaubet, Antoni (Hospital Clínic i Provincial de Barcelona) ; Aburto, Myriam (Hospital Galdakao-Usansolo (Bizkaia)) ; Alfageme, Inmaculada (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Bollo de Miguel, Elena (Complejo Asistencial Universitario de León) ; Cano, Esteban (Hospital Universitario Lucus Augusti (Lugo)) ; Casanova Espinosa, Álvaro (Hospital Universitario del Henares (Madrid)) ; Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ; Figuerola Mendal, J.A. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; García Sevila, Raquel (Hospital General Universitari d'Alacant) ; Gaudó Navarro, Javier I. (Hospital Universitario Ramón y Cajal (Madrid)) ; Gómez-Carrera, Luis (Hospital Universitario La Paz (Madrid)) ; Saez González, Jesus Miguel (Hospital Universitario de Salamanca) ; Herrera Lara, Susana (Hospital Universitari Doctor Peset (València)) ; Laporta Hernández, Rosalía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Marín González, M. (Hospital Clínic Universitari (València)) ; Nieto Barbero, M. Asunción (Hospital Clínico San Carlos (Madrid)) ; Portillo, Karina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Romero, Ana Dolores (Hospital Universitario Virgen de las Nieves (Granada, Andalusia)) ; Sánchez Simón-Talero, Rafaela (Hospital Universitario Nuestra Señora del Perpetuo Socorro (Albacete)) ; Sancho Chust, José N. (Hospital Universitari Sant Joan d'Alacant) ; Sellares, Jacobo (Hospital Clínic i Provincial de Barcelona. Instituto del Tórax) ; Soler-Sempere, Maria J. (Hospital General Universitario de Elche (Alacant)) ; Sauleda, Jaume (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Tomás López, Laura (Hospital Universitario Araba) ; Villanueva, Manuel Angel (Hospital Universitario San Agustín (Aviles, Asturias)) ; Universitat Autònoma de Barcelona
Little is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and clinical profile of IPF patients included in the IPF National Registry of the Spanish Respiratory Society (SEPAR). [...]
2019 - 10.1186/s12931-019-1084-0
Respiratory Research, Vol. 20 Núm. 1 (17 2019) , p. 127  
3.
13 p, 4.1 MB New variants of alpha-1-antitrypsin : structural simulations and clinical expression / Gonzalez, Angel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Belmonte, Irene (Hospital Universitari Vall d'Hebron) ; Núñez, Alexa (Hospital Universitari Vall d'Hebron) ; Farago, Georgina (Hospital Universitari Vall d'Hebron) ; Barrecheguren, Miriam (Hospital Universitari Vall d'Hebron) ; Pons Delgado, Mònica (Hospital Universitari Vall d'Hebron) ; Orriols, Gerard (Hospital Universitari Vall d'Hebron) ; Gabriel-Medina, Pablo (Hospital Universitari Vall d'Hebron) ; Rodríguez Frías, Francisco (Hospital Universitari Vall d'Hebron) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Esquinas, Cristina (Hospital Universitari Vall d'Hebron)
Alpha-1 antitrypsin deficiency (AATD) is characterized by reduced serum levels of the AAT protein and predisposes to liver and lung disease. The characterization at structural level of novel pathogenic SERPINA1 mutants coding for circulating AAT could provide novel insights into the mechanisms of AAT misfolding. [...]
2022 - 10.1186/s12931-022-02271-8
Respiratory Research, Vol. 23 (december 2022)  
4.
20 p, 2.6 MB Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination : a systematic review and meta-analysis / Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; García-Rivero, Juan Luís (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Ribera, Xavier (Boehringer Ingelheim España S.A) ; Galera, Jordi (TFS Health Science) ; García, Alejandra (Market Access AreaPharmalex Spain) ; Palomino, Rosa (Market Access AreaPharmalex Spain) ; Pomares, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Universitat Autònoma de Barcelona
Persistent airflow limitation and dyspnoea may reduce chronic obstructive pulmonary disease (COPD) patients exercise capacity and physical activity, undermining their physical status and quality of life. [...]
2022 - 10.1186/s12931-022-02268-3
Respiratory Research, Vol. 23 (december 2022)  
5.
11 p, 746.6 KB Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation : a population-based study / García-Rio, Francisco (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soriano, Joan B. (Hospital Universitario de la Princesa (Madrid)) ; Cosio, Borja G (Institut d'Investigació Sanitària Illes Balears) ; Soler-Cataluña, Juan José (Hospital Arnau de Vilanova-Lliria) ; Casanova, Ciro (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; de Lucas, Pilar (Hospital General Universitario Gregorio Marañón) ; Alfageme, Inmaculada (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Rodríguez González-Moro, José Miguel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Sánchez Herrero, María Guadalupe (GSK) ; Ancochea, Julio (Hospital Universitario de la Princesa (Madrid)) ; Universitat Autònoma de Barcelona
Population distribution of reduced diffusing capacity of the lungs for carbon monoxide (DLCO) in smokers and main consequences are not properly recognised. The objectives of this study were to describe the prevalence of reduced DLCO in a population-based sample of current and former smoker subjects without airflow limitation and to describe its morphological, functional and clinical implications. [...]
2023 - 10.1136/bmjresp-2022-001468
BMJ Open Respiratory Research, Vol. 10 (january 2023)  
6.
10 p, 923.6 KB Determinants of blood eosinophil levels in the general population and patients with COPD : a population-based, epidemiological study / Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soler-Cataluña, Juan José (Universidad de La Laguna) ; Soriano, Joan B.. (Universidad Autónoma de Madrid) ; García-Rio, Francisco (Hospital Universitario La Paz (Madrid)) ; de Lucas, Pilar (Hospital General Universitario Gregorio Marañón) ; Alfageme, Inmaculada (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Casanova, Ciro (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; Rodríguez González-Moro, José Miguel (Universidad de Alcalá) ; Sánchez-Herrero, M. Guadalupe (GSK, Tres Cantos) ; Ancochea, Julio (Universidad Autónoma de Madrid) ; Cosio, Borja G.. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Universitat Autònoma de Barcelona
Blood eosinophils are considered a biomarker for the treatment of chronic obstructive pulmonary disease (COPD). Population-based studies are needed to better understand the determinants of the blood eosinophil count (BEC) in individuals with and without COPD. [...]
2022 - 10.1186/s12931-022-01965-3
Respiratory Research, Vol. 23 (march 2022)  
7.
11 p, 594.6 KB A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease / Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Cosio, Borja G.. (Institut d'Investigació Sanitària Illes Balears) ; Arnedillo, Aurelio (Universidad de Cádiz) ; Calle Rubio, Myriam (Universidad Complutense de Madrid) ; Alcázar-Navarrete, Bernardino (Hospital de Alta Resolución de Loja) ; González, Cruz (Hospital Clínic Universitari (València)) ; Esteban, Cristóbal (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas) ; Trigueros, Juan Antonio (Centro de Salud Menasalbas) ; Rodríguez González-Moro, José Miguel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Quintano Jiménez, José Antonio (Centro de Salud Lucena I, Lucena, Córdoba, Spain) ; Baloira, Adolfo (Complejo Hospitalario Universitario de Pontevedra) ; Universitat Autònoma de Barcelona
According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. [...]
2017 - 10.1186/s12931-017-0682-y
Respiratory Research, Vol. 18 (november 2017)  
8.
10 p, 1.5 MB Efficacy and safety of tiotropium and olodaterol in COPD : a systematic review and meta-analysis / Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ; Mathioudakis, Alexander G. (The University of Manchester) ; Ancochea, Julio (Hospital Universitario de la Princesa (Madrid)) ; Universitat Autònoma de Barcelona
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of COPD. The new combination of long-acting muscarinic antagonist (LAMA) tiotropium (TIO) and long acting beta-agonists (LABA) olodaterol (OLO) has been introduced as fist line therapy for COPD. [...]
2017 - 10.1186/s12931-017-0683-x
Respiratory Research, Vol. 18 (november 2017)  
9.
10 p, 652.2 KB Altitude and COPD prevalence : analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study / Horner, Andreas (Paracelsus Medical University) ; Soriano, Joan B.. (Instituto de Investigación Hospital Universitario de la Princesa) ; Puhan, Milo A. (University of Zurich Epidemiology, Biostatistics and Prevention Institute) ; Studnicka, Michael (Paracelsus Medical University) ; Kaiser, Bernhard (Johannes-Kepler-University) ; Vanfleteren, Lowie E. G. W. (Program Development Centre) ; Gnatiuc, Louisa (Imperial College) ; Burney, Peter (Imperial College) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García-Rio, Francisco (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Ancochea, Julio (Universidad Autónoma de Madrid) ; Menezes, Ana M. (Universidade Federal de Pelotas) ; Perez-Padilla, Rogelio (Instituto Nacional de Enfermedades Respiratorias) ; Montes de Oca, Maria (Universidad Central de Venezuela) ; Torres-Duque, Carlos A. (Asociación Colombiana de Neumología y Cirugía de Tórax) ; Caballero, Andres (Clínica Reina Sofía, Bogotá, Colombia) ; González-García, Mauricio (Fundación Neumológica Colombiana) ; Buist, Sonia (Oregon Health and Science University) ; Flamm, Maria (Institute of General Practice) ; Lamprecht, Bernd (Johannes-Kepler-University) ; Universitat Autònoma de Barcelona
COPD prevalence is highly variable and geographical altitude has been linked to it, yet with conflicting results. We aimed to investigate this association, considering well known risk factors. A pooled analysis of individual data from the PREPOCOL-PLATINO-BOLD-EPI-SCAN studies was used to disentangle the population effect of geographical altitude on COPD prevalence. [...]
2017 - 10.1186/s12931-017-0643-5
Respiratory Research, Vol. 18 (august 2017)  
10.
12 p, 2.4 MB Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury / Camprubí-Rimblas, Marta (Universitat Autònoma de Barcelona) ; Guillamat-Prats, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Lebouvier, Thomas (Ponchaillou University Hospital) ; Bringué, Josep (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Chimenti, Laura (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Iglesias, Manuela (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Obiols, Carme (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Tijero, Jessica (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Blanch, Lluís (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
In the early stages of acute respiratory distress syndrome (ARDS), pro-inflammatory mediators inhibit natural anticoagulant factors and initiate an increase in procoagulant activity. Previous studies proved the beneficial effects of heparin in pulmonary coagulopathy, which derive from its anticoagulant and anti-inflammatory activities, although it is uncertain whether heparin works. [...]
2017 - 10.1186/s12931-017-0572-3
Respiratory Research, Vol. 18 (may 2017)  

Dipòsit Digital de Documents de la UAB : 22 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.